Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.

Slides:



Advertisements
Similar presentations
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Advertisements

Detection of human telomerase gene (TERC) amplification in cervical neoplasia: A retrospective study of 79 patients Pap smear slides Renarta Crookes Sheffield.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
Comparison of HPV Testing and Spectroscopy Combined with Cytology for the Detection of High- grade Cervical Neoplasia C Werner, W Griffith III, R Ashfaq,D.
COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.
Cervical Cancer Screening Cristin Colford, MD April 27,2010.
Management of Women with CIN 1 or LSIL
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Case Presentations: Pre-Invasive Cervical Neoplasia
AN AUDIT OF PAP SMEAR, COLPOSCOPY AND HISTOLOGY RESULTS FROM IN TUNGARU CENTRAL HOSPITAL (KIRIBATI)
Cervical cancer prevention update
HPV: How to prevent your patients from becoming my patients Katina Robison, MD Assistant Professor, Department of Obstetrics & Gynecology Director of Colposcopy.
Cervical Cancer Screening
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
STUDY OF MULTIMODAL HYPERSPECTROSCOPY IN A POPULATION OF WOMEN AT RISK FOR CERVICAL CANCER Olutosin Awolude α, Brenda Shultz β, Babatunde Akinwunmi α,
PATTERN OF GYNAECOLOGICAL MALIGNANCIES IN DELTA STATE UNIVERSITY TEACHING HOSPITAL,OGHARA:A 2 YEAR REVIEW. MOFON C EBEIGBE P.E ABEDI H.O DELSUTH.
Cervical Cancer Screening Recommendations 2012, FDA Panel 2014.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Current guidelines for Cervical Cancer Screening
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
International Scientific Congress for Students, Young Physicians and Pharmacists Marisiensis 2014.
Cervical Intraepithelial Neoplasm
TEMPLATE DESIGN © Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals.
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
TEMPLATE DESIGN © Negative LLETZ following severe dyskaryosis: a curious phenomenon Üçyiğit A, Jones M H, Dutta A, El.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
NHS Cervical Screening Programme, England, : Graphs.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Cytopathology Feb
Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44; INTERMEDIATE RISK: 31, 33, 35, 51, 52; HIGH RISK: 16, 18, 45, 56.
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
Cancer prevention and early detection
Public Health England leads the NHS Screening Programmes
Human Papilloma Virus Genotype Distribution in Women With Cervical İntraepithelial Neoplasia Mehmet Bülbül1, Berna Dilbaz1, Bilge Aydın Aktürk2, Filiz.
“The challenges of colposcopy in Eastern Europe and Central Asia”
Cancer prevention and early detection
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
NEW SCREENING PROTOCOL WITH DUAL-STAINED CYTOLOGY TRIAGE
Trreatment of Preinvasive Lesions
Colposcopic Biopsy Results of HPV 16 and 18 patients in Bartın
Cost-effectiveness Analysis for Cervical Cancer Screening Using HPV DNA Tests in Chile Franco Figueira S, BPharm student1; Cachoeira CV, MD, MBA1; Silva.
NHS Cervical Screening Programme Introducing HPV Triage
Incidence of CIN2 and 3 and cervical cancer
Cervical Cancer Colposcopy & Treatment
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Facilitator: pawin puapornpong
Ontario Colposcopy Clinical Guidance 2016
An Audit of Colposcopy Practice on Mild Dyskaryosis or Borderline Changes on Cervical Smear and the Effectiveness of “See & Treat” vs. Biopsy and Recall.
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
Retest in 12mo with HPV testing
NHS Cervical Screening Programme, England : Graphs
F.Behnamfar Gynecology Oncology Fellow Professor
Updates on Pap Smear Guidelines 2014
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Public Health England leads the NHS Screening Programmes
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Figure 1: Guidelines for primary cytology# screening in South Africa
Cervical Screening for Dysplasia and Cancer in Patients with HIV
The origins of multidisciplinary cancer care
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Downgrading -IN 2, Diagnoses and Predicting Higher-grade Lesions
Volume 153, Issue 1, Pages (April 2019)
Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.
Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+
Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical.
Presentation transcript:

Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy

Colposcopy has been shown to reduce morbidity and mortality of cervical cancer, it has some limitations due to the concerns about sensitivity of this tool. Several studies have been shown that, colposcopy has a sensitivity ranging between 30-70 % for the detection of high-grade cervical disease Massad LS, Gynecol Oncol 2003 Massad LS. J Low Genit Tract Dis 2009 Pretorius RG. Am J Obstet Gynecol 2004.

Further data indicated increased sensitivity with additional biopsies. Additionally authors suggested that random biopsies are recommended for special populations like women with low grade cytology Gage JC, Obstet Gynecol 2006;108:264–72. Nakamura, Y., International journal of clinical oncology 2015; 20(3): 579-585.

344 patient 2011 – 2016, in Gynecological oncology clinic of Zeynep Kamil Women and Children’s Health Training and Research Hospital. Indications for colposcopy: High risk HPV types, ASC-US, AGC, ASC-H, LSIL,HSIL. Endocervical curettage (ECC) performed patients included.

Frequency of initial cytology were as follows: AGC:6 (1 Frequency of initial cytology were as follows: AGC:6 (1.7 %), ASC-H:33 (9.6), ASC-US:84 (24.4 %), HGSIL:83 (24.1 %), LGSIL:138 (40.1 %). Bu slaytta herkese neden hpv baktınız derlerse bu hastalar asmlerden hem smear hem hpvleri alınarak referre edilen hastalardı diyeceğim. Çünkü hpv değil 2011’de hala dahi bizde bakılmıyor.

Rate of high grade lesions between groups with and without colposcopy directed biopsy was comparable (33/62 versus 119/282, p < 0.05). Random biopsy was obtained in higher cases with high grade cytology (AGC:0/6, ASC-H:5/33, ASC-US:10/84, HGSIL:26/82, LGSIL:20/137, p < 0.05).

Number of cases with variable histopathological results at cervical directed and random biopsy that corresponds to initial cytology   BR Total NCT CIN 1 CIN 2-3 AGC 1 5 6 0.0% 16.7% 83.3% 100.0% ASC-H 10 22 33 3.0% 30.3% 66.7% ASC-US 4 59 21 84 4.8% 70.2% 25.0% HGSIL 2 17 64 83 2.4% 20.5% 77.1% LGSIL 93 40 138 3.6% 67.4% 29.0% 12 180 152 344 3.5% 52.3% 44.2%

cases underwent directed or random biopsy Comparison result of biopsy and ECC results between cases underwent directed or random biopsy Biopsy Results Total NCT CIN 1 CIN 2-3 Random 2 27 33 62 3.2% 43.5% 53.2% 100.0% Directed 10 153 119 282 3.5% 54.3% 42.2% 12 180 152 344 52.3% 44.2% ECC Result 38 11 13 61.3% 17.7% 21.0% 147 32 50 229 64.2% 14.0% 21.8% 185 43 63 291 63.6% 14.8% 21.6% NCT:Normal cervical tissue

Summary of histopathological results at conization and corresponding cytology and biopsy results Conizations Total NCT CIN 1 CIN 2-3 BR/NCT 1 BR/CIN 1 5 14 8 27 BR/CIN2-3 4 25 116 145 9 40 124 173 AGC ASC-H 2 17 24 ASC-US 11 29 HGSIL 52 67 LGSIL 13 34 49

Number of cases with variable histopathological results that corresponds to initial cytology   ECC Total NCT CIN 1 CIN 2-3 AGC 4 2 6 ASC-H 18 12 32 ASC-US 44 11 8 63 HGSIL 39 9 31 79 LGSIL 80 21 10 111 185 43 291 BR/NCT 3 BR/CIN 1 112 24 145 BR/CIN2-3 73 51 134

Our data showed that random cervical biopsy had significant diagnostic value in cases with normal colposcopy. Further analyses of the data of cases with normal colposcopy without visible lesions revealed that, majority of the cases had HSIL cytology.

Consistent with our result, in study by Pretorius et al, random biopsy was shown to have additional value for the detection of CIN 2 or worse especially in cases with high-grade cytology . In their study authors reported that only 57.1 % of women with CIN 2 or worse was detected by colposcopy directed biopsy, although all the colposcopies were satisfactory. Pretorius RG. Am J Obstet Gynecol 2004.

Similar to our argument, the authors of ATHENA study published in 2014 concluded that a single random biopsy increased the detection of high-grade disease when no lesions were visualized at colposcopy and detection rate was shown to be higher in cases with positive for HPV 16 or 18 screening.

Analyses of HPV data showed that, especially in cases with ASC-US cytology, random biopsies were required for non of the case with HPV positivity (n=7), while 10/77 cases underwent random cervical biopsy procedure negative for HPV test.

Random biopsy was performed in higher number of cases with negative for HPV test (1/23 versus 61/321).